Notting Hill, Australia

Penelope Anne Mayes


 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Eltham North, AU (2013)
  • Notting Hill, AU (2013 - 2016)
  • Alpharetta, GA (US) (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Penelope Anne Mayes

Introduction

Penelope Anne Mayes is a distinguished inventor based in Notting Hill, Australia. She has made significant contributions to the field of antiviral compounds, holding a total of seven patents. Her work focuses on developing innovative treatments for viral infections, particularly those affecting the respiratory system.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Polycyclic agents for the treatment of respiratory syncytial virus infections." This invention relates to polycyclic antiviral compounds, their salts, methods for their preparation, and compositions containing them. It emphasizes the use of these compounds in treating viral infections. The second patent is "Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections." This invention involves compounds that are useful in treating respiratory syncytial virus (RSV) infections, along with processes for preparing these compounds and their intermediates.

Career Highlights

Penelope is currently associated with Biota Scientific Management Pty Ltd, where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the field of antiviral research.

Collaborations

Throughout her career, Penelope has collaborated with notable colleagues, including Jeffrey Peter Mitchell and Alistair George Draffan. These collaborations have further enriched her research and contributed to her success in the field.

Conclusion

Penelope Anne Mayes is a remarkable inventor whose work in antiviral compounds has the potential to significantly impact the treatment of viral infections. Her dedication to innovation and collaboration continues to drive advancements in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…